BWV - Blue Water to collaborate with Brazil's Butantan to develop universal flu shot candidate

Blue Water Vaccines (NASDAQ:BWV) on Thursday said it is collaborating with Brazil's Instituto Butantan to develop Blue Water's universal influenza vaccine candidate, BWV-101. The collaboration is with the Center for R&D in Immunobiologics, a Butantan initiative. Butantan is the largest distributor and supplier of vaccines in Brazil. It also manufactures 100% of the influenza vaccine doses used by Brazil's health ministry. According to its website, Butantan produces 100M of the 170M vaccine doses dispensed annually by the Brazilian immunization program. Cincinnati, Ohio-based BWV is developing a universal influenza vaccine that could potentially provide lifelong protection from influenza, including pandemic strains like the 1918 pandemic and 2009 swine flu. BWV stock -1.1% to $4.60 in afternoon trade.

For further details see:

Blue Water to collaborate with Brazil's Butantan to develop universal flu shot candidate